Top Abstract Purchase Related
Home
>
Node
>
Subnode

The course and outcome of viral hepatitis B in drug-addicted patients

Tat'ianko, N.V.; Gromashevskaia, L.L.; Vovk, A.D.; Kasatkina, M.G.; Liashok, O.V.; Matiash, V.I.; Iasinovyĭ, S.P.; Kovgan, I.N.

Likars'ka Sprava 1996(5-6): 119-122

1996

ISSN/ISBN: 1019-5297
PMID: 9377374
Document Number: 466500
In this paper, characterization is given of clinical and biochemical features of VH B course against the background of narcomania. Recordable in such patient populations are high percentage of delta hepatitis (14.2%), unusual severity of the intoxication syndrome, protracted course with exacerbations (12.2%) and recurrences (8%), outcome being a chronic hepatitis (14.2%), slower normalization of biochemical indicators, persistently low ratio of AIAT activity in diluted and whole blood sera. The persistence of viral markers in drug addicts discharged from the hospital (68%) is fraught with danger of spreading viral hepatitis of prophylactic measures are not strictly observed.

Document emailed within 1 workday
Secure & encrypted payments

Cerrato, G.; Badii, F. 1983: Psychologic study of a group of drug dependent patients hospitalized for acute viral hepatitis Minerva Psichiatrica 24(2): 47-52
Markov, I.S.; Barshteĭn, I.A. 1988: Fatal outcome in superinfection of non-A, non-B viral hepatitis Vrachebnoe Delo 5: 106-107
Gol'zand, I.V.; Blagoslovenskiĭ, G.S.; Vasil'eva, N.A. 1972: Clinical features and outcome of anicteric forms of viral hepatitis Klinicheskaia Meditsina 50(3): 26-31
Diaz Lestrem, M.; Fainboim, H.; Mendez, N.; Boxaca, M.; Libonatti, O.; Calello, M.A.; Astarloa, L.; Weissenbacher, M. 1988: Prevalencia de infección por el VIH-1 en enfermos de hepatitis vírica con antecedente de toxicomanía por inyección - Prévalence de l'infection à HIV1 chez les sujets atteints d'hépatite virale ayant des antécédents de toxicomanie par voie intraveineuse - Prevalence of HIV1 infection in viral hepatitis patients with an history of intraveinous drug abuse Boletin de la Oficina Sanitaria Panamericana 105(5-6): 510-516
González-Michaca, L.; Mercado, A.; Gamba, G. 2000: Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(5): 491-496
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Sagnelli, C.; Ciccozzi, M.; Pisaturo, M.; Lo Presti, A.; Cella, E.; Coppola, N.; Sagnelli, E. 2015: The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy New Microbiologica 38(2): 137-147
Pak, S.G.; Brodov, L.E.; Burnatseva, V.V.; Bogin, I.B. 1980: Clinical aspects of VZ viral hepatitis and the aggravating effect of herpes zoster on the course of infectious and serum viral hepatitis Klinicheskaia Meditsina 58(5): 47-49
Cheng, I.K.; Ho, S.K.; Fang, G.X.; Chan, D.T.; Lai, C.L. 1996: Usefulness of measurement of serum viral DNA using dot-blot hybridization and polymerase chain reaction in renal transplant patients with hepatitis B-positive viral infection Transplantation Proceedings 28(3): 1493-1494
Nishiguchi, S.; Kuroki, T.; Ueda, T.; Fukuda, K.; Takeda, T.; Nakajima, S.; Shiomi, S.; Kobayashi, K.; Otani, S.; Hayashi, N. 1992: Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis Annals of Internal Medicine 116(1): 21-25
Rzeszowska, G.; Mazurek, E.; Mierzejewska, I.; Fijałka-Rymar, M.; Ignaciuk, A. 1987: Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 42: 89-94
Curciarello, J.O.; Corallini, O.; Adrover, R.E.; Chiera, A.O.; Giammona, A.M.; Barbero, R.; Apraiz, M.; Belloni, P.O.; Neumann, M.; Jmelnitzky, A.C. 1994: Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients Acta Gastroenterologica Latinoamericana 25(5): 291-296
Fried, M.W.; Shindo, M.; Fong, T.L.; Fox, P.C.; Hoofnagle, J.H.; Di Bisceglie, A.M. 1992: Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C Gastroenterology 102(4 Part 1): 1306-1308
Borón, P.; Sokolewicz-Bobrowska, E.; Dzikowski, M. 1974: Demonstration of hepatitis B antigen in relation to the behavior of liver indicator-enzymes patients with viral hepatitis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(24): 1016-1018
Bocşan, I.S.; Gocan, G.; Ursu, L.; Brumboiu, M.I.; Soşa, I.; Simionca, L.; Sava, A.ţa.; Olaru, O.; Păştina, I. 2005: How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(1): 124-130
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Aleĭnik, M.D. 1970: Epidemiologic patterns in the spread of viral hepatitis. I. Dynamics of viral hepatitis morbidity Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 47(1): 63-66
Shudo, E.; Ribeiro, R.M.; Talal, A.H.; Perelson, A.S. 2008: A hepatitis C viral kinetic model that allows for time-varying drug effectiveness Antiviral Therapy 13(7): 919-926
Lucht, F.; Berthelot, P.; Job, P.; Bonnevial, L.; Digonnet, C.; Fresard, A.; Chabert, B.; Cabal, C.; Pozzetto, B. 1996: Seroprevalence of viral hepatitis a in France in homosexuals and intravenous drug users Presse Medicale 25(25): 1141-1143